Precigen, Inc.
NASDAQ:PGENBiotechnology
-$0.10 today
- Market cap
- $1.49B
- Beta
- 1.06
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$0.65
Volume 4.37M
Average 4.72M
Returns on capital
Precigen, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-1198.6%
avg -215.5%
ROIC
-88.5%
avg -47.1%
ROA
-160.0%
avg -48.0%
Analysis
ROIC is currently the strongest return metric at -88.5% versus its period average of -47.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Helen Sabzevari | President, Chief Executive Officer & Director | USD 2.07M | 64 | 229.17K | 0.08% |
Donald Lehr | Chief Legal Officer & Corporate Secretary | USD 754.15K | 51 | — | — |
Phil Tennant | Chief Commercial Officer | USD 691.55K | 56 | 120.83K | 0.04% |
Rutul R. Shah | Chief Operating Officer | USD 676.1K | 45 | 73.30K | 0.02% |
Harry Thomasian Jr. | Chief Financial Officer | USD 655.52K | 64 | 46.81K | 0.02% |
Randal J. Kirk | Executive Chairman | USD 100K | 73 | 302.21K | 0.10% |
Amy R. Lankford | Senior VP & Global Head of Regulatory Affairs | — | — | — | — |
Bryan T. Butman | Senior Vice President & Head of CMC | — | 73 | — | — |
Douglas E. Brough | Senior Vice President & Head of Research | — | 71 | — | — |
Steven Harasym | Vice President & Head of Investor Relations | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 23, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$24,661.53
Sells
41
$39.93M
Net Transaction Value
−$39.91M
Net selling
Most Active
KIRK RANDAL J
24 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 26, 26Aug 26, 2026 | KINDLER JEFFREY B Direct | Sell | $1.4M$1,376,400.00 |
| Aug 25, 26Aug 25, 2026 | Shah Rutul R Direct | Sell | $115.1K$115,065.00 |
| Aug 25, 26Aug 25, 2026 | Tennant Phil Direct | Sell | $593.7K$593,745.00 |
| Aug 21, 26Aug 21, 2026 | AGEE NANCY H Direct | Buy | $24.7K$24,661.53 |
| Aug 21, 26Aug 21, 2026 | Shah Rutul R Direct | Sell | $259.9K$259,935.00 |
| Aug 6, 26Aug 6, 2026 | Shah Rutul R Direct | Sell | $224.6K$224,589.54 |
| Aug 3, 26Aug 3, 2026 | Shah Rutul R Direct | Sell | $219.5K$219,518.00 |
| Jul 31, 26Jul 31, 2026 | Thomasian Harry Jr. Direct | Sell | $606K$606,000.00 |
| Jul 1, 26Jul 1, 2026 | Thomasian Harry Jr. Direct | Sell | $948K$948,002.37 |
| Jun 29, 26Jun 29, 2026 | Shah Rutul R Direct | Sell | $251.1K$251,105.40 |
1–10 of 42
Summary
Insiders reported 1 buys worth $24,661.53 and 41 sells worth $39.93M over the last 12 months. That adds up to net selling of $39.91M. KIRK RANDAL J was the most active insider with 24 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -28.9% | +152.8% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at -28.9% over three years. Forward estimates point to Revenue at +152.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Precigen, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about PGEN's management, answered from reported figures.
Who manages PGEN?
Precigen, Inc. (PGEN) lists 10 active executives. The top listed executive is Amy R. Lankford, Senior VP & Global Head of Regulatory Affairs.
Are PGEN insiders buying or selling?
Recent insider activity shows net selling of $34.84M.
Continue the stock analysis
Jump to another research area for this company.